• UCLA Health
  • myUCLAhealth
  • School of Medicine
UCLA Rheumatology

UCLA Rheumatology

UCLA Rheumatology
  • About Us
    • Locations, Maps, & Directions
    • Contact Us
    • News & Events
    • How You Can Make a Difference
  • Clinical Programs & Conditions
    • Lupus
    • Myositis
    • Gout
    • Vasculitis
    • Connective Tissue Disease - Interstitial Lung Disease (CTD-ILD)
    • Scleroderma
    • Ultrasound
  • For Patients
  • Research
  • Fellowship
    • Fellows
    • Training Sites
    • Sample Schedule
    • Salary/Benefits
  • For Referring Physicians
  • Our Doctors
  • UCLA Health
  • myUCLAhealth
  • School of Medicine

UCLA Rheumatology

About Us

About Us

About Us

  • Locations, Maps, & Directions
  • Contact Us
  • News & Events
  • How You Can Make a Difference
  • Locations, Maps, & Directions
  • Contact Us
  • News & Events
  • How You Can Make a Difference
  1. Home
  2. About Us
  3. News & Events

News & Events

Share this

ACR Convergence 2021

UCLA's Division of Rheumatology was well represented at the 2021 ACR Convergence with 23 posters, 5 abstracts, 3 plenaries, 3 industry sessions, 3 community sessions, 1 review course, and 1 study group. Congratulations to the faculty and fellows who contribute to the presentations this year!

Posters:

  • ANCA Positivity and ANCA Associated Vasculitis in Patients with Rheumatoid Arthritis
  • Suppressed Paraoxonase-1 Activity and Elevated Oxylipins Associate with the Presence of Small Airways Disease in Patients with Rheumatoid Arthritis
  • Economic and Healthcare Resource Use Burden of Systemic Sclerosis
  • Safety and Tolerability of Nintedanib in Patients with Autoimmune Disease-Related Interstitial Lung Diseases: Pooled Data from the SENSCIS and INBUILD Trials
  • Severity and Impact of Gastrointestinal Symptoms in Patients with SSc-ILD Treated with Nintedanib: Data from SENSCIS-ON
  • Decreased HDL Levels and Antioxidant Function in Juvenile Dermatomyositis
  • Suppression of HDL-associated Apolipoprotein A-I (apoA-I) Levels in Patients with Idiopathic Inflammatory Myopathies
  • Lower HDL-associated Apolipoprotein A-I Levels Associate with Presence of Calcinosis in Adult Dermatomyositis
  • Molecular Heterogeneity Between Different Classes of Lupus Nephritis as Revealed by Kidney Biopsy Proteomics
  • Are Current Patient Reported Outcomes Instruments Optimized to Capture the Entire Patient Experience?
  • Safety and Tolerability of IVIg (Octagam 10%) in Patients with Active Dermatomyositis. Results of a Randomized, Double-Blind, Placebo-Controlled Phase III Trial
  • Paraoxonase-1: Potential Novel Marker of Disease Extent and Activity in Systemic Sclerosis
  • Autologous Hematopoietic Stem Cell (HSC) Transplantation for Systemic Sclerosis, North American Registry: Updated Outcomes and the Impact of CD34+ HSC Enrichment
  • NLP-Based Clustering Methods Can Efficiently Categorize Scientific Abstracts for Medical Conferences
  • “What Matters”: Patient and Clinician Perspectives in Psoriatic Arthritis Care
  • Associations of Esophageal Dysmotility Patterns with Extra-intestinal Features in Patients with Systemic Sclerosis
  • Outcomes of COVID-19 Illness in Systemic Autoinflammatory Diseases and Changes in Flares During the COVID-19 Pandemic: An International Survey
  • Severity of Gastroesophageal Reflux, but Not the Use of Proton Pump Inhibitors, Is Associated with Radiographic Progression of Interstitial Lung Disease in Systemic Sclerosis
  • Effect of Nintedanib in Patients with Systemic Sclerosis-associated Interstitial Lung Disease and Risk Factors for Rapid Decline in Forced Vital Capacity: Further Analyses of the SENSCIS Trial
  • Peripheral Blood Cell Gene Expression Profiling Predicts Response to Mycophenolate in Systemic Sclerosis Related Interstitial Lung Disease
  • Integrated Laboratory Abnormality Profiles of Upadacitinib with up to 4.5 Years of Exposure in Patients with Rheumatoid Arthritis Treated in a Phase 3 Clinical Trial
  • Clinical Characteristics and Reliability of a Self-Reported Diagnosis of Large-Vessel Vasculitis
  • Description of an Internet-Based Cohort with a Self-Reported Diagnosis of Polyarteritis Nodosa

Plenaries:

  • Lupus Nephritis Mortality in the United States, 1999-2019: Profound Disparities by Race/Ethnicity and Place of Residence and a Recent Worsening Trend
  • Risk Factors for Major Adverse Cardiovascular Events in Patients Aged ≥ 50 Years with RA and ≥ 1 Additional Cardiovascular Risk Factor: Results from a Phase 3b/4 Randomized Safety Study of Tofacitinib vs TNF Inhibitors
  • Genotype and Transfusion Dependence Predicts Mortality in VEXAS Syndrome, a Newly Described Disease with Overlap Inflammatory and Hematologic Features

Oral Abstract Sessions: 

  • Background Mycophenolate (MMF) Treatment Is Associated with Improved Outcomes in a Phase 3 Trial of Lenabasum in Diffuse Cutaneous Systemic Sclerosis (dcSSc)
  • Relationship Between Paraoxonase-1 Genotype, Activity, and Malignancies in Patients with RA Receiving Tofacitinib
  • Trends in Adverse Pregnancy Outcomes Among Women with Systemic Sclerosis in the United States
  • Clinical Heterogeneity of the VEXAS Syndrome: A Case Series
  • The Risk of Venous Thromboembolic Events in Patients with RA Aged ≥ 50 Years with ≥ 1 Cardiovascular Risk Factor: Results from a Phase 3b/4 Randomized Safety Study of Tofacitinib vs TNF Inhibitors

Review Courses:

  • Impact of Rheumatic Disease Management on Cardiovascular Risk

Study Groups:

  • Humanities in Medicine – Rheum for More Insight

 

Industry Sessions:

  • SAPHNELO™ (anifrolumab-fnia): The First-in Class Type 1 Interferon (IFN-1) Signaling Inhibitor
  • Treatment Priorities in Systemic Lupus Erythematosus: Focus on Musculoskeletal Symptoms and Patient-Reported Outcomes
  • Woman Leaders in Rheumatology: Leadership in a Virtual World

Community Hub Sessions:

  • CH Ultrasound: The Business of MSUS
  • CH SLE: Meet the Masters: Reflections on Lupus in 2021?
  • CH Leadership: Cocktail Hour: Creating the Ideal Work / Life Balance?

Return to Rheumatology Homepage

Like Us on Facebook Follow Us on Twitter Subscribe to Our Videos on YouTube Follow us on Instagram Connect with Us on LinkedIn Follow us on Pinterest
UCLA Health hospitals ranked best hospitals by U.S. News & World Report
  • UCLA Health
  • Find a Doctor
  • School of Medicine
  • School of Nursing
  • UCLA Campus
  • Directory
  • Newsroom
  • Subscribe
  • Patient Stories
  • Giving
  • Careers
  • Volunteer
  • International Services
  • Privacy Practices
  • Nondiscrimination
  • Billing
  • Health Plans
  • Emergency
  • Report Broken Links
  • Terms of Use
  • 1-310-825-2631
  • Maps & Directions
  • Contact Us
  • Your Feedback
  • Report Misconduct
  • Get Social
  • Sitemap
Like Us on Facebook Follow Us on Twitter Subscribe to Our Videos on YouTube Follow us on Instagram Connect with Us on LinkedIn Follow us on Pinterest

Sign in to myUCLAhealth

Learn more about myUCLAhealth